Literature DB >> 9621021

Requirement for cellular cyclin-dependent kinases in herpes simplex virus replication and transcription.

L M Schang1, J Phillips, P A Schaffer.   

Abstract

Several observations indicate that late-G1/S-phase-specific cellular functions may be required for herpes simplex virus (HSV) replication: (i) certain mutant HSV strains are replication impaired during infection of cells in the G0/G1 but not in the G1/S phase of the cell cycle, (ii) several late-G1/S-phase-specific cellular proteins and functions are induced during infection, and (iii) the activity of a cellular protein essential for expression of viral immediate-early (IE) genes, HCF, is normally required during the late G1/S phase of the cell cycle. To test the hypothesis that late-G1/S-phase-specific cellular functions are necessary for HSV replication, HEL or Vero cells were infected in the presence of the cell cycle inhibitors roscovitine (Rosco) and olomoucine (Olo). Both drugs inhibit cyclin-dependent kinase 1 (cdk-1) and cdk-2 (required for cell cycle progression into the late G1/S phase) and cdk-5 (inactive in cycling cells) but not cdk-4 or cdk-6 (active at early G1). We found that HSV replication was inhibited by Rosco and Olo but not by lovastatin (a cell cycle inhibitor that does not inhibit cdk activity), staurosporine (a broad-spectrum protein serine-threonine kinase inhibitor), PD98059 (an inhibitor specific for erk-1 and -2) or iso-Olo (a structural isomer of Olo that does not inhibit cdk activity). The concentrations of Rosco and Olo required to inhibit cell cycle progression and viral replication in both HEL and Vero cells were similar. Inhibition of viral replication was found not to be mediated by drug-induced cytotoxicity. Efforts to isolate Rosco- or Olo-resistant HSV mutants were unsuccessful, indicating that these drugs do not act by inhibiting a single viral target. Viral DNA replication and accumulation of IE and early viral RNAs were inhibited in the presence of cell cycle-inhibitory concentrations of Rosco or Olo. We therefore conclude that one or more cdks active from late G1 onward or inactive in nonneuronal cells are required for accumulation of HSV transcripts, viral DNA replication, and production of infectious virus.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9621021      PMCID: PMC110224     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  Herpes simplex virus immediate early gene expression in the absence of transinduction by Vmw65 varies during the cell cycle.

Authors:  J I Daksis; C M Preston
Journal:  Virology       Date:  1992-07       Impact factor: 3.616

Review 2.  Phosphorylation of transcriptional factors and cell-cycle-dependent proteins by casein kinase II.

Authors:  H Meisner; M P Czech
Journal:  Curr Opin Cell Biol       Date:  1991-06       Impact factor: 8.382

3.  Viral transactivators E1A and VP16 interact with a large complex that is associated with CTD kinase activity and contains CDK8.

Authors:  M O Gold; J P Tassan; E A Nigg; A P Rice; C H Herrmann
Journal:  Nucleic Acids Res       Date:  1996-10-01       Impact factor: 16.971

4.  RNA polymerase II is aberrantly phosphorylated and localized to viral replication compartments following herpes simplex virus infection.

Authors:  S A Rice; M C Long; V Lam; C A Spencer
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

5.  n-Butyrate, a cell cycle blocker, inhibits the replication of polyomaviruses and papillomaviruses but not that of adenoviruses and herpesviruses.

Authors:  F F Shadan; L M Cowsert; L P Villarreal
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

6.  Purification of the cellular C1 factor required for the stable recognition of the Oct-1 homeodomain by the herpes simplex virus alpha-trans-induction factor (VP16).

Authors:  T M Kristie; P A Sharp
Journal:  J Biol Chem       Date:  1993-03-25       Impact factor: 5.157

7.  Inhibition of cyclin-dependent kinases by purine analogues.

Authors:  J Veselý; L Havlicek; M Strnad; J J Blow; A Donella-Deana; L Pinna; D S Letham; J Kato; L Detivaud; S Leclerc
Journal:  Eur J Biochem       Date:  1994-09-01

8.  Distinct roles for cyclin-dependent kinases in cell cycle control.

Authors:  S van den Heuvel; E Harlow
Journal:  Science       Date:  1993-12-24       Impact factor: 47.728

9.  Activation of second-messenger pathways reactivates latent herpes simplex virus in neuronal cultures.

Authors:  R L Smith; L I Pizer; E M Johnson; C L Wilcox
Journal:  Virology       Date:  1992-05       Impact factor: 3.616

10.  Olomoucine, an inhibitor of the cdc2/cdk2 kinases activity, blocks plant cells at the G1 to S and G2 to M cell cycle transitions.

Authors:  N Glab; B Labidi; L X Qin; C Trehin; C Bergounioux; L Meijer
Journal:  FEBS Lett       Date:  1994-10-17       Impact factor: 4.124

View more
  72 in total

1.  Efficient activation of viral genomes by levels of herpes simplex virus ICP0 insufficient to affect cellular gene expression or cell survival.

Authors:  W E Hobbs; D E Brough; I Kovesdi; N A DeLuca
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  The murine gammaherpesvirus 68 v-cyclin gene is an oncogene that promotes cell cycle progression in primary lymphocytes.

Authors:  L F van Dyk; J L Hess; J D Katz; M Jacoby; S H Speck; I V Virgin HW
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

3.  Posttranslational processing of infected cell proteins 0 and 4 of herpes simplex virus 1 is sequential and reflects the subcellular compartment in which the proteins localize.

Authors:  S J Advani; R Hagglund; R R Weichselbaum; B Roizman
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

4.  The role of cdc2 in the expression of herpes simplex virus genes.

Authors:  S J Advani; R R Weichselbaum; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

Review 5.  Herpesvirus lytic replication and the cell cycle: arresting new developments.

Authors:  E K Flemington
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

Review 6.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

7.  E2F proteins are posttranslationally modified concomitantly with a reduction in nuclear binding activity in cells infected with herpes simplex virus 1.

Authors:  S J Advani; R R Weichselbaum; B Roizman
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

8.  Explant-induced reactivation of herpes simplex virus occurs in neurons expressing nuclear cdk2 and cdk4.

Authors:  Luis M Schang; Andrew Bantly; Priscilla A Schaffer
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

9.  Inhibition of S-phase cyclin-dependent kinase activity blocks expression of Epstein-Barr virus immediate-early and early genes, preventing viral lytic replication.

Authors:  Ayumi Kudoh; Tohru Daikoku; Yutaka Sugaya; Hiroki Isomura; Masatoshi Fujita; Tohru Kiyono; Yukihiro Nishiyama; Tatsuya Tsurumi
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

10.  Inhibition of HTLV-1 transcription by cyclin dependent kinase inhibitors.

Authors:  Lai Wang; Longwen Deng; Kaili Wu; Cynthia de la Fuente; Dai Wang; Kylene Kehn; Anil Maddukuri; Shanese Baylor; Francisco Santiago; Emmanuel Agbottah; Sylviane Trigon; Michel Morange; Renaud Mahieux; Fatah Kashanchi
Journal:  Mol Cell Biochem       Date:  2002-08       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.